The association between estimated glomerular filtration rate, albuminuria, and risk of cardiovascular hospitalizations and all-cause mortality among patients with type 2 diabetes

We evaluated the simultaneous effects of all clinically recognized categories of albuminuria and estimated glomerular filtration rate (eGFR) on cardiovascular disease (CVD) and mortality We conducted a longitudinal observational study of 16,678 type 2 diabetes (T2D) patients. From the first serum cr...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of diabetes and its complications 2018-03, Vol.32 (3), p.291-297
Hauptverfasser: Nichols, Gregory A., Déruaz-Luyet, Anouk, Hauske, Sibylle J., Brodovicz, Kimberly G.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 297
container_issue 3
container_start_page 291
container_title Journal of diabetes and its complications
container_volume 32
creator Nichols, Gregory A.
Déruaz-Luyet, Anouk
Hauske, Sibylle J.
Brodovicz, Kimberly G.
description We evaluated the simultaneous effects of all clinically recognized categories of albuminuria and estimated glomerular filtration rate (eGFR) on cardiovascular disease (CVD) and mortality We conducted a longitudinal observational study of 16,678 type 2 diabetes (T2D) patients. From the first serum creatinine value from 2006 to 2012 and a urine-albumin creatinine ratio (UACR) recorded within 6months, we applied baseline Kidney Disease: Improving Global Outcomes (KDIGO) categories of eGFR and albuminuria. We followed patients for up to 11years to calculate adjusted incidence per 1000person-years (p-y) of first CVD hospitalization and all-cause mortality. Over 98,069p-y of follow-up, CVD hospitalization risk was greater for each higher eGFR and albuminuria category. In eGFR category G2 (60-89mL/min/1.73m2), adjusted incidence per 1000p-y was 14.1 (95% CI 12.9-15.5), 19.8 (17.2-22.8), and 22.8 (17.4-30.0) for normoalbuminuria, microalbuminuria and macroalbuminuria, respectively. For eGFR category G3a (45-59), rates were 26.7 (22.3-32.0), 40.3 (32.2-50.5), and 44.1 (28.8-67.4), respectively. Adjusted risk of all-cause mortality followed a similar pattern. Our data underscore the importance of including detailed eGFR and UACR values in assessing CVD risk. High albuminuria and low eGFR is a potent predictor of CVD and death.
doi_str_mv 10.1016/j.jdiacomp.2017.12.003
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1989609980</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S1056872717315234</els_id><sourcerecordid>1989609980</sourcerecordid><originalsourceid>FETCH-LOGICAL-c396t-84e2731d573784184043b50093446d7e46e4c7dc68536a2fb2ab3f91587bd96f3</originalsourceid><addsrcrecordid>eNqFkcFu1DAQhiMEoqXwCpUlLhxIsGPHjm-gqhSkSlyKxM1y7EnXixMH22m1PBZPWO9uy4ELp7Hl758Z_39VnRPcEEz4h22ztU6bMC1Ni4loSNtgTJ9Vp6QXtGYc_3hezrjjdS9acVK9SmmLMeZdR15WJ62kXcslPa3-3GwA6ZSCcTq7MKMB8j3AjCBlN-kMFt36MEFcvY5odD7HI1cKvEfaD-vk5jU6XS6zRdGlnyiMyOhoXbjTyRyEm5AWl7V3vw_qdGC197XRawI0hbh_zDukpzDfoqVQMOeE7l3eoLxbALWo_LcsB-l19WLUPsGbx3pWff98eXPxpb7-dvX14tN1bajkue4ZtIIS2wkqekZ6hhkdOowlZYxbAYwDM8Ia3neU63YcWj3QUZKuF4OVfKRn1btj3yWGX2vxQ00uGfBezxDWpIjsJcdS9rigb_9Bt2GNc9lOlXRkz0VHWKH4kTIxpBRhVEssHsedIljtU1Vb9ZTqXicUaVVJtQjPH9uvwwT2r-wpxgJ8PAJQ_LhzEFUyxUAD1kUwWdng_jfjAVFUul0</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2019867514</pqid></control><display><type>article</type><title>The association between estimated glomerular filtration rate, albuminuria, and risk of cardiovascular hospitalizations and all-cause mortality among patients with type 2 diabetes</title><source>MEDLINE</source><source>Access via ScienceDirect (Elsevier)</source><source>ProQuest Central UK/Ireland</source><creator>Nichols, Gregory A. ; Déruaz-Luyet, Anouk ; Hauske, Sibylle J. ; Brodovicz, Kimberly G.</creator><creatorcontrib>Nichols, Gregory A. ; Déruaz-Luyet, Anouk ; Hauske, Sibylle J. ; Brodovicz, Kimberly G.</creatorcontrib><description>We evaluated the simultaneous effects of all clinically recognized categories of albuminuria and estimated glomerular filtration rate (eGFR) on cardiovascular disease (CVD) and mortality We conducted a longitudinal observational study of 16,678 type 2 diabetes (T2D) patients. From the first serum creatinine value from 2006 to 2012 and a urine-albumin creatinine ratio (UACR) recorded within 6months, we applied baseline Kidney Disease: Improving Global Outcomes (KDIGO) categories of eGFR and albuminuria. We followed patients for up to 11years to calculate adjusted incidence per 1000person-years (p-y) of first CVD hospitalization and all-cause mortality. Over 98,069p-y of follow-up, CVD hospitalization risk was greater for each higher eGFR and albuminuria category. In eGFR category G2 (60-89mL/min/1.73m2), adjusted incidence per 1000p-y was 14.1 (95% CI 12.9-15.5), 19.8 (17.2-22.8), and 22.8 (17.4-30.0) for normoalbuminuria, microalbuminuria and macroalbuminuria, respectively. For eGFR category G3a (45-59), rates were 26.7 (22.3-32.0), 40.3 (32.2-50.5), and 44.1 (28.8-67.4), respectively. Adjusted risk of all-cause mortality followed a similar pattern. Our data underscore the importance of including detailed eGFR and UACR values in assessing CVD risk. High albuminuria and low eGFR is a potent predictor of CVD and death.</description><identifier>ISSN: 1056-8727</identifier><identifier>EISSN: 1873-460X</identifier><identifier>DOI: 10.1016/j.jdiacomp.2017.12.003</identifier><identifier>PMID: 29352693</identifier><language>eng</language><publisher>United States: Elsevier Inc</publisher><subject>Aged ; Albuminuria ; Albuminuria - complications ; Cardiovascular disease ; Cardiovascular Diseases - epidemiology ; Creatinine - metabolism ; Diabetes ; Diabetes Mellitus, Type 2 - complications ; Diabetes Mellitus, Type 2 - metabolism ; Diabetes Mellitus, Type 2 - mortality ; Diabetic Angiopathies - epidemiology ; Diabetic kidney disease ; eGFR ; Female ; Generalized linear models ; Glomerular Filtration Rate ; Health risk assessment ; Heart failure ; Hospitalization ; Humans ; Incidence ; Kidney diseases ; Laboratories ; Longitudinal Studies ; Male ; Middle Aged ; Mortality ; Survival Rate</subject><ispartof>Journal of diabetes and its complications, 2018-03, Vol.32 (3), p.291-297</ispartof><rights>2017</rights><rights>Copyright © 2017. Published by Elsevier Inc.</rights><rights>Copyright Elsevier Limited Mar 2018</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c396t-84e2731d573784184043b50093446d7e46e4c7dc68536a2fb2ab3f91587bd96f3</citedby><cites>FETCH-LOGICAL-c396t-84e2731d573784184043b50093446d7e46e4c7dc68536a2fb2ab3f91587bd96f3</cites><orcidid>0000-0002-7563-6236</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.proquest.com/docview/2019867514?pq-origsite=primo$$EHTML$$P50$$Gproquest$$H</linktohtml><link.rule.ids>314,780,784,3550,27924,27925,45995,64385,64387,64389,72469</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/29352693$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Nichols, Gregory A.</creatorcontrib><creatorcontrib>Déruaz-Luyet, Anouk</creatorcontrib><creatorcontrib>Hauske, Sibylle J.</creatorcontrib><creatorcontrib>Brodovicz, Kimberly G.</creatorcontrib><title>The association between estimated glomerular filtration rate, albuminuria, and risk of cardiovascular hospitalizations and all-cause mortality among patients with type 2 diabetes</title><title>Journal of diabetes and its complications</title><addtitle>J Diabetes Complications</addtitle><description>We evaluated the simultaneous effects of all clinically recognized categories of albuminuria and estimated glomerular filtration rate (eGFR) on cardiovascular disease (CVD) and mortality We conducted a longitudinal observational study of 16,678 type 2 diabetes (T2D) patients. From the first serum creatinine value from 2006 to 2012 and a urine-albumin creatinine ratio (UACR) recorded within 6months, we applied baseline Kidney Disease: Improving Global Outcomes (KDIGO) categories of eGFR and albuminuria. We followed patients for up to 11years to calculate adjusted incidence per 1000person-years (p-y) of first CVD hospitalization and all-cause mortality. Over 98,069p-y of follow-up, CVD hospitalization risk was greater for each higher eGFR and albuminuria category. In eGFR category G2 (60-89mL/min/1.73m2), adjusted incidence per 1000p-y was 14.1 (95% CI 12.9-15.5), 19.8 (17.2-22.8), and 22.8 (17.4-30.0) for normoalbuminuria, microalbuminuria and macroalbuminuria, respectively. For eGFR category G3a (45-59), rates were 26.7 (22.3-32.0), 40.3 (32.2-50.5), and 44.1 (28.8-67.4), respectively. Adjusted risk of all-cause mortality followed a similar pattern. Our data underscore the importance of including detailed eGFR and UACR values in assessing CVD risk. High albuminuria and low eGFR is a potent predictor of CVD and death.</description><subject>Aged</subject><subject>Albuminuria</subject><subject>Albuminuria - complications</subject><subject>Cardiovascular disease</subject><subject>Cardiovascular Diseases - epidemiology</subject><subject>Creatinine - metabolism</subject><subject>Diabetes</subject><subject>Diabetes Mellitus, Type 2 - complications</subject><subject>Diabetes Mellitus, Type 2 - metabolism</subject><subject>Diabetes Mellitus, Type 2 - mortality</subject><subject>Diabetic Angiopathies - epidemiology</subject><subject>Diabetic kidney disease</subject><subject>eGFR</subject><subject>Female</subject><subject>Generalized linear models</subject><subject>Glomerular Filtration Rate</subject><subject>Health risk assessment</subject><subject>Heart failure</subject><subject>Hospitalization</subject><subject>Humans</subject><subject>Incidence</subject><subject>Kidney diseases</subject><subject>Laboratories</subject><subject>Longitudinal Studies</subject><subject>Male</subject><subject>Middle Aged</subject><subject>Mortality</subject><subject>Survival Rate</subject><issn>1056-8727</issn><issn>1873-460X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2018</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>8G5</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><sourceid>GNUQQ</sourceid><sourceid>GUQSH</sourceid><sourceid>M2O</sourceid><recordid>eNqFkcFu1DAQhiMEoqXwCpUlLhxIsGPHjm-gqhSkSlyKxM1y7EnXixMH22m1PBZPWO9uy4ELp7Hl758Z_39VnRPcEEz4h22ztU6bMC1Ni4loSNtgTJ9Vp6QXtGYc_3hezrjjdS9acVK9SmmLMeZdR15WJ62kXcslPa3-3GwA6ZSCcTq7MKMB8j3AjCBlN-kMFt36MEFcvY5odD7HI1cKvEfaD-vk5jU6XS6zRdGlnyiMyOhoXbjTyRyEm5AWl7V3vw_qdGC197XRawI0hbh_zDukpzDfoqVQMOeE7l3eoLxbALWo_LcsB-l19WLUPsGbx3pWff98eXPxpb7-dvX14tN1bajkue4ZtIIS2wkqekZ6hhkdOowlZYxbAYwDM8Ia3neU63YcWj3QUZKuF4OVfKRn1btj3yWGX2vxQ00uGfBezxDWpIjsJcdS9rigb_9Bt2GNc9lOlXRkz0VHWKH4kTIxpBRhVEssHsedIljtU1Vb9ZTqXicUaVVJtQjPH9uvwwT2r-wpxgJ8PAJQ_LhzEFUyxUAD1kUwWdng_jfjAVFUul0</recordid><startdate>201803</startdate><enddate>201803</enddate><creator>Nichols, Gregory A.</creator><creator>Déruaz-Luyet, Anouk</creator><creator>Hauske, Sibylle J.</creator><creator>Brodovicz, Kimberly G.</creator><general>Elsevier Inc</general><general>Elsevier Limited</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7RV</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>8G5</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AN0</scope><scope>ASE</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FPQ</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>K6X</scope><scope>K9-</scope><scope>K9.</scope><scope>KB0</scope><scope>M0R</scope><scope>M0S</scope><scope>M1P</scope><scope>M2O</scope><scope>MBDVC</scope><scope>NAPCQ</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>Q9U</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0002-7563-6236</orcidid></search><sort><creationdate>201803</creationdate><title>The association between estimated glomerular filtration rate, albuminuria, and risk of cardiovascular hospitalizations and all-cause mortality among patients with type 2 diabetes</title><author>Nichols, Gregory A. ; Déruaz-Luyet, Anouk ; Hauske, Sibylle J. ; Brodovicz, Kimberly G.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c396t-84e2731d573784184043b50093446d7e46e4c7dc68536a2fb2ab3f91587bd96f3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2018</creationdate><topic>Aged</topic><topic>Albuminuria</topic><topic>Albuminuria - complications</topic><topic>Cardiovascular disease</topic><topic>Cardiovascular Diseases - epidemiology</topic><topic>Creatinine - metabolism</topic><topic>Diabetes</topic><topic>Diabetes Mellitus, Type 2 - complications</topic><topic>Diabetes Mellitus, Type 2 - metabolism</topic><topic>Diabetes Mellitus, Type 2 - mortality</topic><topic>Diabetic Angiopathies - epidemiology</topic><topic>Diabetic kidney disease</topic><topic>eGFR</topic><topic>Female</topic><topic>Generalized linear models</topic><topic>Glomerular Filtration Rate</topic><topic>Health risk assessment</topic><topic>Heart failure</topic><topic>Hospitalization</topic><topic>Humans</topic><topic>Incidence</topic><topic>Kidney diseases</topic><topic>Laboratories</topic><topic>Longitudinal Studies</topic><topic>Male</topic><topic>Middle Aged</topic><topic>Mortality</topic><topic>Survival Rate</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Nichols, Gregory A.</creatorcontrib><creatorcontrib>Déruaz-Luyet, Anouk</creatorcontrib><creatorcontrib>Hauske, Sibylle J.</creatorcontrib><creatorcontrib>Brodovicz, Kimberly G.</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Nursing &amp; Allied Health Database</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Research Library (Alumni Edition)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>British Nursing Database</collection><collection>British Nursing Index</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>British Nursing Index (BNI) (1985 to Present)</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>British Nursing Index</collection><collection>Consumer Health Database (Alumni Edition)</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Nursing &amp; Allied Health Database (Alumni Edition)</collection><collection>Consumer Health Database</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Research Library</collection><collection>Research Library (Corporate)</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of diabetes and its complications</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Nichols, Gregory A.</au><au>Déruaz-Luyet, Anouk</au><au>Hauske, Sibylle J.</au><au>Brodovicz, Kimberly G.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>The association between estimated glomerular filtration rate, albuminuria, and risk of cardiovascular hospitalizations and all-cause mortality among patients with type 2 diabetes</atitle><jtitle>Journal of diabetes and its complications</jtitle><addtitle>J Diabetes Complications</addtitle><date>2018-03</date><risdate>2018</risdate><volume>32</volume><issue>3</issue><spage>291</spage><epage>297</epage><pages>291-297</pages><issn>1056-8727</issn><eissn>1873-460X</eissn><abstract>We evaluated the simultaneous effects of all clinically recognized categories of albuminuria and estimated glomerular filtration rate (eGFR) on cardiovascular disease (CVD) and mortality We conducted a longitudinal observational study of 16,678 type 2 diabetes (T2D) patients. From the first serum creatinine value from 2006 to 2012 and a urine-albumin creatinine ratio (UACR) recorded within 6months, we applied baseline Kidney Disease: Improving Global Outcomes (KDIGO) categories of eGFR and albuminuria. We followed patients for up to 11years to calculate adjusted incidence per 1000person-years (p-y) of first CVD hospitalization and all-cause mortality. Over 98,069p-y of follow-up, CVD hospitalization risk was greater for each higher eGFR and albuminuria category. In eGFR category G2 (60-89mL/min/1.73m2), adjusted incidence per 1000p-y was 14.1 (95% CI 12.9-15.5), 19.8 (17.2-22.8), and 22.8 (17.4-30.0) for normoalbuminuria, microalbuminuria and macroalbuminuria, respectively. For eGFR category G3a (45-59), rates were 26.7 (22.3-32.0), 40.3 (32.2-50.5), and 44.1 (28.8-67.4), respectively. Adjusted risk of all-cause mortality followed a similar pattern. Our data underscore the importance of including detailed eGFR and UACR values in assessing CVD risk. High albuminuria and low eGFR is a potent predictor of CVD and death.</abstract><cop>United States</cop><pub>Elsevier Inc</pub><pmid>29352693</pmid><doi>10.1016/j.jdiacomp.2017.12.003</doi><tpages>7</tpages><orcidid>https://orcid.org/0000-0002-7563-6236</orcidid></addata></record>
fulltext fulltext
identifier ISSN: 1056-8727
ispartof Journal of diabetes and its complications, 2018-03, Vol.32 (3), p.291-297
issn 1056-8727
1873-460X
language eng
recordid cdi_proquest_miscellaneous_1989609980
source MEDLINE; Access via ScienceDirect (Elsevier); ProQuest Central UK/Ireland
subjects Aged
Albuminuria
Albuminuria - complications
Cardiovascular disease
Cardiovascular Diseases - epidemiology
Creatinine - metabolism
Diabetes
Diabetes Mellitus, Type 2 - complications
Diabetes Mellitus, Type 2 - metabolism
Diabetes Mellitus, Type 2 - mortality
Diabetic Angiopathies - epidemiology
Diabetic kidney disease
eGFR
Female
Generalized linear models
Glomerular Filtration Rate
Health risk assessment
Heart failure
Hospitalization
Humans
Incidence
Kidney diseases
Laboratories
Longitudinal Studies
Male
Middle Aged
Mortality
Survival Rate
title The association between estimated glomerular filtration rate, albuminuria, and risk of cardiovascular hospitalizations and all-cause mortality among patients with type 2 diabetes
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-23T16%3A04%3A09IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=The%20association%20between%20estimated%20glomerular%20filtration%20rate,%20albuminuria,%20and%20risk%20of%20cardiovascular%20hospitalizations%20and%20all-cause%20mortality%20among%20patients%20with%20type%202%20diabetes&rft.jtitle=Journal%20of%20diabetes%20and%20its%20complications&rft.au=Nichols,%20Gregory%20A.&rft.date=2018-03&rft.volume=32&rft.issue=3&rft.spage=291&rft.epage=297&rft.pages=291-297&rft.issn=1056-8727&rft.eissn=1873-460X&rft_id=info:doi/10.1016/j.jdiacomp.2017.12.003&rft_dat=%3Cproquest_cross%3E1989609980%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2019867514&rft_id=info:pmid/29352693&rft_els_id=S1056872717315234&rfr_iscdi=true